These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34630502)

  • 41. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
    Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA SOX2-OT regulates proliferation and metastasis of nasopharyngeal carcinoma cells through miR-146b-5p/HNRNPA2B1 pathway.
    Zhang E; Li X
    J Cell Biochem; 2019 Oct; 120(10):16575-16588. PubMed ID: 31099048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1.
    Su C; Huang DP; Liu JW; Liu WY; Cao YO
    Oncol Lett; 2019 Sep; 18(3):2825-2834. PubMed ID: 31452761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCL12 gene silencing down-regulates metastatic potential via blockage of MAPK/PI3K/AP-1 signaling pathway in colon cancer.
    Ma J; Su H; Yu B; Guo T; Gong Z; Qi J; Zhao X; Du J
    Clin Transl Oncol; 2018 Aug; 20(8):1035-1045. PubMed ID: 29305742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
    Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
    Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
    Luo X; Cao M; Gao F; He X
    Exp Hematol Oncol; 2021 Jun; 10(1):35. PubMed ID: 34088349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The CircRNA-ACAP2/Hsa-miR-21-5p/ Tiam1 Regulatory Feedback Circuit Affects the Proliferation, Migration, and Invasion of Colon Cancer SW480 Cells.
    He JH; Li YG; Han ZP; Zhou JB; Chen WM; Lv YB; He ML; Zuo JD; Zheng L
    Cell Physiol Biochem; 2018; 49(4):1539-1550. PubMed ID: 30212824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
    Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
    Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diclofenac induced apoptosis via altering PI3K/Akt/MAPK signaling axis in HCT 116 more efficiently compared to SW480 colon cancer cells.
    Arisan ED; Ergül Z; Bozdağ G; Rencüzoğulları Ö; Çoker-Gürkan A; Obakan-Yerlikaya P; Coşkun D; Palavan-Ünsal N
    Mol Biol Rep; 2018 Dec; 45(6):2175-2184. PubMed ID: 30406888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
    Calvo N; Carriere P; Martin MJ; Gentili C
    J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK Pathway.
    Cai M; Liang X; Sun X; Chen H; Dong Y; Wu L; Gu S; Han S
    Front Oncol; 2019; 9():164. PubMed ID: 30941313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
    Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
    J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.
    Cheng XS; Huo YN; Fan YY; Xiao CX; Ouyang XM; Liang LY; Lin Y; Wu JF; Ren JL; Guleng B
    J Cell Mol Med; 2020 Aug; 24(15):8391-8404. PubMed ID: 32614521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.